Biosimilars

The Highs and Lows of Manufacturing a Biosimilar

This podcast features: Philip Ridley-Smith, Business Development Manager, Cobra Biologics [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0048.mp3″]     This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting…

Developing and Manufacturing Biosimilars and Biobetters

This podcast features: Michiel E. Ultee, PhD, Chief Scientific Officer, Laureate Biopharma[sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0046.mp3″]     This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends…

ROUNDTABLE: Pfenex and Agila Biotech Biosimilars Joint Venture – The Convergence of Expression & Manufacturing Technology Harnessing the Emerging Market Opportunity

This podcast features: Dr. Bertrand Liang, Chief Executive Officer, Pfenex Inc Dr. Anand Iyer, Chief Executive Officer, Agila Biotech Encik Rizatuddin “Ritz†Ramli, Chief Executive Officer, Malaysian Bio-XCell Sdn Bhd Daniel Bauer, Commercial Executive, FlexFactory Facilities, Xcellerex, Inc, A GE Healthcare Company [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0045.mp3″]     This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the…

Biosimilars: Challenges and Solutions

This podcast features: Jeffrey Su, PhD, Chief Scientific Officer, Cytovance Biologics[sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0047.mp3″]     This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting…

ROUNDTABLE: Biosimilar Development Concerns – Collaboration, Capacity, and CMOs

This podcast features: Chairperson: Patti Seymour, Senior Consultant, BioProcess Technology Consultants Speaker/Panelists: Thomas J. Vanden Boom, Vice President, Global Biologics Research, Hospira Dr. Uwe Buecheler, Senior Vice President, Biopharmaceutical Operations, Boehringer Ingelheim Michiel E. Ultee, PhD, Chief Scientific Officer, Laureate Biopharma Richard Brudnick, Vice President, BD/M&A, BiogenIdec [sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Biosimilars/TASCAM_0049.mp3″]     This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on…